• #1120534
  • 472
  • Sanofi Pasteur #49281063115

Fluzone® Quadrivalent 2019 - 2020 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Multiple Dose Vial 5 mL

FLUZONE 2019 QUAD, MDV 5ML (10DOSE/VL)

Features
  • Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Multi-dose vial, 5 mL, for persons 6 months of age and older
  • Fluzone Quadrivalent (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs
  • More …
Container Type
Multiple Dose Vial Prefilled Syringe Single Dose Vial
Volume
0.5 mL 5 mL
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1120534
Manufacturer #49281063115
BrandFluzone® Quadrivalent 2019 - 2020
ManufacturerSanofi Pasteur
Country of OriginUnknown
ApplicationFlu Vaccine
Container TypeMultiple Dose Vial
Dosage FormInjection
NDC Number49281063115
Storage RequirementsRequires Refrigeration
Strength60 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 6 Months of Age and Above
Volume5 mL
Features
  • Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Multi-dose vial, 5 mL, for persons 6 months of age and older
  • Fluzone Quadrivalent (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs
  • Fluzone Quadrivalent is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following four influenza strains recommended for the 2019-2020 influenza season: A/Michigan/45/2015 X-275 (H1N1), A/Hong Kong/4801/2014 X-263B (H3N2), B/Phuket/3073/2013 (B Yamagata lineage), and B/Brisbane/60/2008 (B Victoria lineage)
  • The 5 mL multi-dose vial presentation contains thimerosal, a mercury derivative, added as a preservative
  • Each 0.5 mL dose from the multi-dose vial contains 25 mcg mercury
  • Each 0.25 mL dose from the multi-dose vial contains 12.5 mcg mercury
  • 6 to 35 months 0.25 mL ; 3 years and above 0.5 mL
More Information